Overview

• Guangdong province has recorded more than 8,000 chikungunya infections concentrated in Foshan as aggressive vector-control measures including fumigation and habitat removal are implemented.
• France and Italy have reported 49 and two autochthonous chikungunya cases respectively, prompting heightened surveillance along shared borders and public awareness campaigns.
• Spanish health authorities estimate 50 to 100 imported chikungunya cases annually and have reinforced diagnostic protocols along with tiger mosquito reduction strategies in Mediterranean regions.
• There is no specific antiviral treatment for chikungunya, so clinical care focuses on symptomatic relief with paracetamol and adequate hydration.
• A vaccine developed by Bavarian Nordic showing 85–90 percent efficacy in research trials is expected to enter the market soon pending real-world safety and effectiveness evaluations.